相关实验视频
Updated: Jan 15, 2026

09:55
Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis
Published on: October 25, 2024
1.5K
血动脉生成指数与发生性大动脉疾病之间的关联:基于人口的前性分析
Cuihong Tian1,2,3,4,5, Xiao Wang6, Liang Tao6
1Department of Cardiology, First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong 515041, China.
Open heart
|October 10, 2025
概括
血动脉生成指数 (AIP) 与大动脉疾病,特别是大动脉动脉瘤的风险更高有关. 这一发现表明,AIP是评估大动脉疾病风险的宝贵工具.
科学领域:
- 心血管研究的心血管研究.
- 脂质学 脂质学是指脂质学.
- 大动脉疾病研究研究
背景情况:
- 血动脉生成指数 (AIP) 是一种基于脂质的生物标志物.
- AIP反映了原蛋白对心脏代谢健康的影响和保护性脂蛋白的影响.
- AIP与大动脉疾病风险之间的关联尚未得到充分证实.
研究的目的:
- 调查AIP与发生大动脉疾病的风险之间的关联.
- 确定AIP是否可以作为大动脉疾病的有效风险评估工具.
主要方法:
- 一项大规模,基于人口的前性队列研究,使用英国生物库数据.
- 分析了17530名年龄在40-70岁之间的参与者.
- 大动脉疾病 (大动脉解剖和大动脉动脉瘤) 是复合结果,随访时间中位数为15.1年.
主要成果:
- 在AIP和发生性大动脉疾病风险之间观察到线性趋势 (p=0.134).
- 升高的AIP三位数显示大动脉疾病风险逐步增加 (三位数aHR=2.04).
- 最高的AIP三位数与大动脉动脉瘤风险增加显著相关 (aHR=2.47).
结论:
- AIP与发生性大动脉疾病的风险增加有显著的关联.
- AIP显示出作为大动脉疾病,特别是大动脉动脉瘤的有效风险评估方法的潜力.
相关概念视频
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
465
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
465
Atherosclerosis I: Introduction
916
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
916
Coronary Artery Disease I: Introduction
878
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
878
Aneurysm II: Clinical Manifestations and Diagnostic Studies
293
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
293
Peripheral Artery Disease I: Introduction
313
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
313
Atherosclerosis III: Management
319
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
319
